Academy for Continued Healthcare Learning
Obesity is a chronic, progressive, and relapsing disease that imposes a substantial clinical burden. Despite the availability of approved pharmacologic agents with varying mechanisms of action, efficacy, tolerability, and accessibility, only a small percentage of eligible patients are prescribed evidence-based medications, often due to clinician knowledge gaps, concerns regarding long-term safety, and a persistent but inaccurate perception of obesity as a failure of willpower rather than a multifactorial neuroendocrine disorder. Clinicians also encounter significant limitations with available
Before you enroll
Unlocking the Therapeutic Potential of Amylin-Based Therapies for Obesity is offered by Academy for Continued Healthcare Learning for physicians. Topics in this listing: Clinical practice.
Check the credit type and approval notes below against your credential. The provider handles enrollment, completion and the certificate.
Provider-designated AMA PRA Category 1 Credit. AAPA, AANP and ANCC reciprocity is provider-stated where disclosed; verify acceptance for your credential.
Listed roles: Physician
State scope: No individual state acceptance claim is made in this listing.
ACCMEThe provider identifies this activity as free continuing education. Complete the stated assessment and claiming requirements.
The recorded cost is $0 for learning, assessment and the certificate, with no separate reporting fee identified. Academy for Continued Healthcare Learning requires a free account. The provider identifies this activity as free continuing education. Complete the stated assessment and claiming requirements.
The provider lists 1 CME. Recorded roles: Physician. Match the individual track below to your credential and board before enrolling.
This is an on-demand activity in the current collection; follow the source link to begin. The recorded credit expiration date is 2027-08-07.
Create an ACHL account, complete the pretest, view the online activity, and score at least 66% on the posttest. Complete the evaluation. The certificate is immediately available at no fee. Completion and certificate delivery are handled by Academy for Continued Healthcare Learning; saving this listing does not enroll you or claim credit.
These are the primary pages supporting this listing. Course recognition and board acceptance should be confirmed for your credential before enrollment.
Your next credential
Preparing for an exam, too? Explore free practice questions and explanations on OpenExamPrep.
OpenExamPrepFree exam preparationThese are exam-preparation resources, separate from continuing education credit. Exam registration fees and eligibility are set by the exam sponsor.
Exploring the Therapeutic Potential of Emerging Therapies in Pulmonary Fibrosis. A free accredited ACHL enduring CME/CE activity.
Asparaginase, a cornerstone of regimens for acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) in pediatric and adult patients, is frequently complicated by a distinct spectrum of toxicities which pose significant clinical management challenges. The management of ALL/LBL in adolescent and young adults (AYA) is particularly complex, and these patients often have reduced survival due to their unique needs, challenges with transitions of care, and divergent management across different providers and settings.To mitigate barriers and improve outcomes in patients with ALL/LBL, this
No two patients with generalized myasthenia gravis (gMG) are the same and individualizing treatment is vital. Clinicians must integrate factors such as age of onset, autoantibody profile, clinical manifestation, gender, and thymic pathology to classify gMG subtypes and tailor treatment strategies. The treatment armamentarium has also recently expanded with novel agents and expanded indications, further complicating decisions.To help clinicians interpret and apply the growing body of evidence in treatment selection across gMG subtypes, this point-counterpoint digital activity uses case-based di
